ERGIC1

Endoplasmic reticulum-Golgi intermediate compartment protein 1 · Q969X5 · ERGIC1 on Sugi Atlas →

0 patent compounds predicted against ERGIC1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ERGIC1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phenylbutyrate in Proteinuric Nephropathies PHASE2/PHASE3COMPLETED
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM) PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Quantification of GADD34 Expression in RA nanCOMPLETED
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders nanUNKNOWN
A Multicenter Phenotype-Genotype Analysis of LGMD Patients in China nanENROLLING_BY_INVITATION
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study nanRECRUITING
Pediatric Evaluation and Registry for Liver Cholestasis in Canada nanRECRUITING
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms nanCOMPLETED
Tracking Neurodegeneration in Early Wolfram Syndrome nanCOMPLETED
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
The Prevalence of RYR1-related Disease nanNOT_YET_RECRUITING
GNAO1 Natural History Study nanUNKNOWN
Human Epididymis Protein 4 in Endometrial Carcinoma nanCOMPLETED
sCD163 in ALS Patients nanCOMPLETED
Brain Involvement in Dystrophinopathies Part 2 nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Inherited Reproductive Disorders nanRECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression nanNOT_YET_RECRUITING
Surfactant Derived Protocol in Heart Failure nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ERGIC1 binder may also engage these)

ProteinNameSimilarity
Q9DC16 1.000 Q9DC16 →
Q4V8Y6 0.959 Q4V8Y6 →
P35438 0.940 P35438 →
P35439 0.939 P35439 →
GRIN1 Glutamate receptor ionotropic, NMDA 1 0.935 landscape →
Q13888 0.933 Q13888 →
Q6NS19 0.932 Q6NS19 →
A0A1L8F5J9 0.932 A0A1L8F5J9 →
Q6P1K8 0.928 Q6P1K8 →
Q5R1P0 0.927 Q5R1P0 →
TMED2 Transmembrane emp24 domain-containing protein 2 0.926 landscape →
Q63524 0.924 Q63524 →
Q2TBV5 0.924 Q2TBV5 →
Q9WV18 0.924 Q9WV18 →
P23438 0.923 P23438 →
P49020 0.923 P49020 →
Q9R0Q3 0.923 Q9R0Q3 →
Q8R4D1 0.922 Q8R4D1 →
GABBR1 Gamma-aminobutyric acid type B receptor subunit 1 0.921 landscape →
Q5E9E4 0.920 Q5E9E4 →
Q5F398 0.920 Q5F398 →
P79101 0.920 P79101 →
Q9Z0U4 0.919 Q9Z0U4 →
Q4L208 0.919 Q4L208 →
P61203 0.918 P61203 →
COPS2 COP9 signalosome complex subunit 2 0.918 landscape →
P43308 0.917 P43308 →
Q9UKF6 0.917 Q9UKF6 →
Q5ZJ75 0.917 Q5ZJ75 →
Q6IQT4 0.916 Q6IQT4 →